Usana Health Sciences (USNA) Capital Expenditures (2011 - 2026)

Usana Health Sciences (USNA) has reported Capital Expenditures for 16 consecutive years, with $3.2 million the latest figure, recorded in Q3 2026.

• On a quarterly basis, Capital Expenditures fell 37.24% year-over-year to $3.2 million in Q3 2026; TTM through Jul 2026 was $11.8 million, a 1.98% decrease from a year earlier, with the FY2026 full-year figure at $13.8 million, up 37.23% from the prior year.
• Capital Expenditures was $3.2 million for Q3 2026 at Usana Health Sciences, up from $2.6 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $7.3 million in Q4 2023 and troughed at -$847000.0 in Q1 2022.
• A 5-year average of $2.8 million and a median of $2.8 million in 2026 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures surged 487.84% in 2022 and plunged 75.4% in 2024, its largest moves.
• Over 5 years, Capital Expenditures stood at $3.3 million in 2022, then jumped by 122.95% to $7.3 million in 2023, then sank by 75.4% to $1.8 million in 2024, then jumped by 77.47% to $3.2 million in 2025, then fell by 1.34% to $3.2 million in 2026.
• The last three Capital Expenditures figures came in at $3.2 million (Q3 2026), $2.6 million (Q2 2026), and $2.8 million (Q1 2026), per Business Quant data.